Exicure

XCURNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$8.573 M

$1.35 -0.37%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$4.95M

Loss-making

Shares outstanding

6,373,937

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#434Quoin PharmaceuticalsQNRX$9.62M
#435Lexaria BioscienceLEXX$8.71M
#436ExicureXCUR$8.57M
#437Processa PharmaceuticalsPCSA$8.55M
#438SoligenixSNGX$8.53M

Where these numbers come from

Share counts and financials for Exicure are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.